Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

PURPOSE. Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs). Published data suggest that EGFR addiction persists after development of TKI acquired resistance, leading many clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Goldberg, Sarah B., Oxnard, Geoffrey R., Digumarthy, Subba, Muzikansky, Alona, Jackman, David M., Lennes, Inga T., Sequist, Lecia V.
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2013
Materias:
Lung Cancer
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825307/
https://ncbi.nlm.nih.gov/pubmed/24072220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0168
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares